MA24473A1 - Formulations - Google Patents

Formulations

Info

Publication number
MA24473A1
MA24473A1 MA24964A MA24964A MA24473A1 MA 24473 A1 MA24473 A1 MA 24473A1 MA 24964 A MA24964 A MA 24964A MA 24964 A MA24964 A MA 24964A MA 24473 A1 MA24473 A1 MA 24473A1
Authority
MA
Morocco
Prior art keywords
formulations
Prior art date
Application number
MA24964A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703099.3A external-priority patent/GB9703099D0/en
Priority claimed from GBGB9703101.7A external-priority patent/GB9703101D0/en
Priority claimed from GBGB9703100.9A external-priority patent/GB9703100D0/en
Application filed by Smithkline Beecham Corp, Smithkline Beecham Lab filed Critical Smithkline Beecham Corp
Publication of MA24473A1 publication Critical patent/MA24473A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
MA24964A 1997-02-14 1998-02-12 Formulations MA24473A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9703099.3A GB9703099D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703101.7A GB9703101D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703100.9A GB9703100D0 (en) 1997-02-14 1997-02-14 Formulations

Publications (1)

Publication Number Publication Date
MA24473A1 true MA24473A1 (fr) 1998-10-01

Family

ID=27268719

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24964A MA24473A1 (fr) 1997-02-14 1998-02-12 Formulations

Country Status (25)

Country Link
EP (2) EP1142574A1 (fr)
JP (1) JP2001512451A (fr)
KR (1) KR100499812B1 (fr)
CN (1) CN1194687C (fr)
AP (1) AP1253A (fr)
AT (1) ATE243516T1 (fr)
AU (1) AU728526B2 (fr)
BG (1) BG103664A (fr)
BR (1) BR9807383A (fr)
CA (1) CA2280857A1 (fr)
DE (1) DE69815833T2 (fr)
DZ (1) DZ2420A1 (fr)
EA (1) EA002595B1 (fr)
ES (1) ES2201468T3 (fr)
HK (1) HK1043041A1 (fr)
ID (1) ID23673A (fr)
IL (1) IL131201A (fr)
MA (1) MA24473A1 (fr)
NO (1) NO993887D0 (fr)
NZ (1) NZ337043A (fr)
OA (1) OA11087A (fr)
PL (1) PL334976A1 (fr)
SK (1) SK110299A3 (fr)
TR (1) TR199901961T2 (fr)
WO (1) WO1998035672A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DK0862431T3 (da) 1995-09-07 2002-03-11 Smithkline Beecham Plc Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
WO2000050036A1 (fr) * 1999-02-26 2000-08-31 Biovail International Ltd. Composition sous forme de suspension a stockage stable a base d'amoxycilline et de clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IL145580A0 (en) * 1999-04-13 2002-11-10 Beecham Pharm Pte Ltd A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
FR2797588B1 (fr) * 1999-08-20 2003-08-01 Smithkline Beecham Lab Formulation pharmaceutique a base d'amoxycilline et de clavulanate
AU6571400A (en) * 1999-08-20 2001-03-19 Smithkline Beecham Laboratoires Pharmaceutiques S.A.S. Pharmaceutical formulation comprising amoxycillin and clavulanate
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
WO2003063820A2 (fr) * 2002-02-01 2003-08-07 Sandoz Gmbh Granulats stables a la segregation
ES2314227T7 (es) * 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
CN1681497A (zh) * 2002-07-16 2005-10-12 兰贝克赛实验室有限公司 口服给药用的可分散片剂
KR20060010838A (ko) * 2003-06-16 2006-02-02 글락소 그룹 리미티드 아목시실린 및 클라블라네이트를 포함하는 약제학적 제형
KR100676617B1 (ko) * 2004-06-18 2007-01-30 주식회사유한양행 아목시실린 및/또는 클라불란산 또는 이의 염을 함유하는경구용 현탁정제 조성물
SI21912A (sl) * 2004-12-24 2006-06-30 Lek Farmacevtska Druzba D.D. Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN100464750C (zh) * 2006-02-23 2009-03-04 珠海联邦制药股份有限公司 一种制备含阿莫西林钠和克拉维酸钾的药物混合物的方法
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20070521A7 (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
WO2009135946A1 (fr) 2008-05-09 2009-11-12 Atacama Labs Oy Procédé et appareil de granulation par voie sèche
CN102861015B (zh) * 2011-07-05 2015-07-08 北京乐维生物技术有限公司 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺
WO2014065769A1 (fr) * 2012-10-22 2014-05-01 Bilgiç Mahmut Formulations pour suspensions orales comprenant des antibiotiques
ES2780874T3 (es) * 2013-09-20 2020-08-27 Centrient Pharmaceuticals Netherlands B V Comprimido que comprende crospovidona
US9254261B2 (en) * 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
KR102002906B1 (ko) * 2016-10-18 2019-07-23 경동제약 주식회사 셀레콕시브를 포함하는 정제
EP3994154A1 (fr) 2019-07-05 2022-05-11 GlaxoSmithKline Intellectual Property (No.2) Limited Streptomyces clavuligerus
CN113274357B (zh) * 2021-05-28 2022-12-27 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物及其制备方法
CN114869884A (zh) * 2021-07-30 2022-08-09 江苏恒丰强生物技术有限公司 一种用于猪呼吸道疾病的复方阿莫西林粉及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
EP1034784A3 (fr) * 1993-01-22 2001-06-27 Smithkline Beecham Plc Formulations pharmaceutique contenant d'acide clavulanique et un agent antibacterien
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ1926A1 (fr) * 1994-09-03 2002-02-17 Smithkline Beckman P L C Formulations pharmaceutiques.

Also Published As

Publication number Publication date
AP9901623A0 (en) 1999-09-30
EP1142574A1 (fr) 2001-10-10
PL334976A1 (en) 2000-03-27
BG103664A (en) 2000-03-31
DZ2420A1 (fr) 2003-01-04
ATE243516T1 (de) 2003-07-15
DE69815833D1 (de) 2003-07-31
CA2280857A1 (fr) 1998-08-20
KR100499812B1 (ko) 2005-07-08
CN1251990A (zh) 2000-05-03
OA11087A (en) 2003-03-13
NO993887L (no) 1999-08-12
ES2201468T3 (es) 2004-03-16
AU728526B2 (en) 2001-01-11
TR199901961T2 (xx) 1999-11-22
DE69815833T2 (de) 2004-05-19
BR9807383A (pt) 2000-03-14
EP0975342B1 (fr) 2003-06-25
KR20000071076A (ko) 2000-11-25
HK1043041A1 (en) 2002-09-06
IL131201A (en) 2005-06-19
JP2001512451A (ja) 2001-08-21
AU6719698A (en) 1998-09-08
EA199900647A1 (ru) 2000-06-26
WO1998035672A1 (fr) 1998-08-20
NZ337043A (en) 2001-02-23
SK110299A3 (en) 2000-08-14
NO993887D0 (no) 1999-08-12
CN1194687C (zh) 2005-03-30
AP1253A (en) 2004-03-17
EA002595B1 (ru) 2002-06-27
IL131201A0 (en) 2001-01-28
EP0975342A1 (fr) 2000-02-02
ID23673A (id) 2000-05-11

Similar Documents

Publication Publication Date Title
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
NO20004240L (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
PT973527E (pt) Formulacoes de libertacao prolongada de claritromicina
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
PT1130966E (pt) Formulacoes antiparasitarias
FI973042A0 (fi) Bildkompressering
DE59803185D1 (de) Baulaser
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59710388D1 (de) Mikropolarimeter
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
ID23663A (id) Persiapan kaprolaktam
ATA46498A (de) Kunststoffgleitbahn
ATA86797A (de) Verschleissschuh
DE59800820D1 (de) Stiellose kniegelenkendoprothese
BR9701194A (pt) Hidrociclo
DE59804542D1 (de) Arylaminomethylencampherderivate
ATE421585T1 (de) Motlinhomologe
BR9704162A (pt) Anti-queimaduras